Chong Xu

Chong Xu

Director/Board Member en K36 Therapeutics, Inc. .

43 años
Finance
Health Technology
Consumer Services

Perfil

Chong Xu is currently a Director at Geneception, Inc., K36 Therapeutics, Inc., Shanghai Rarestone Health Tech Group Co. Ltd., and Partner at Impresa Management LLC.
Previously, Dr. Xu worked as a Director at Adagene, Inc. from 2020 to 2021, an Equity Analyst at Massif Partners Holdings LP, an Associate at McKinsey & Co., Inc., an Analyst at Affirmed Capital LLC, and a Principal at Eight Roads Ventures Japan.
Dr. Xu holds a doctorate degree from the University of Virginia, an undergraduate degree from Zhejiang University, and an MBA from the University of Virginia Darden School of Business.

Cargos activos de Chong Xu

EmpresasCargoInicio
Private Equity Investor -
Director/Board Member -
Director/Board Member -
Director/Board Member -
Todos los cargos activos de Chong Xu

Antiguos cargos conocidos de Chong Xu.

EmpresasCargoFin
ADAGENE INC. Director/Board Member 08/02/2021
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Analyst-Equity -
Ver el detalle de la experiencia de Chong Xu.

Formación de Chong Xu.

University of Virginia Doctorate Degree
Zhejiang University Undergraduate Degree
University of Virginia Darden School of Business Masters Business Admin

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Chong Xu.

Relaciones

99

Relaciones de 1er grado

12

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas1
ADAGENE INC.

Health Technology

Empresas privadas8

Finance

Commercial Services

Finance

Finance

Finance

Health Technology

Health Technology

Health Technology

Ver las conexiones de la empresa